White & Case LLP International Law Firm, Global Law Practice -
Pharmaceuticals & Healthcare
Global pharmaceutical and healthcare companies face a range of
challenges: disputes over intellectual property (IP), adherence to
evolving government regulation and parallel trade challenges, to name
only a few. Great opportunity exists as well. Growth is possible
through strategic acquisitions, joint ventures, licensing,
distribution, supply agreements and international trade. With our
unique worldwide capabilities, including deep experience in the US, UK
and EU regimes, we understand the business and legal intricacies that
pharmaceutical and healthcare companies face on a daily basis. We
work with many of the leading global players in the pharmaceutical and
healthcare sector on their dispute resolution, corporate and
transactional needs (major financings, M&A transactions, litigation,
etc.). We advise pharmaceutical multinationals on the full range of
IP, antitrust, commercial litigation and M&A issues across the United
States, Europe and Asia. Our lawyers have litigated and won some of
the biggest pharmaceutical cases in history. We successfully litigate
high-profile patent cases, and advise on the full spectrum of
IP-related work. In the US, we are the most experienced of any law
firm in so-called "reverse payment" cases brought by the Federal Trade
Commission and/or private plaintiffs. We try high-stakes
pharmaceutical cases in the US and represent pharmaceutical clients in
some of the most-watched matters of the day. In Europe, we have led
the way on parallel trade and other issues in the sector.We also offer
clients strong capabilities in other areas such as the Foreign Corrupt
Practices Act, the False Claims Act, international arbitration, tax,
environmental and international trade. We have deep connections with
relevant national and international regulatory bodies in the
pharmaceuticals and healthcare sector. We offer clients unparalleled
experience in defending branded, specialty, and generic pharmaceutical
firms against antitrust-based challenges. Our experience includes
government and private litigation, trials and appeals. Our work on
behalf of pharmaceutical clients includes defending claims such as
"product-hopping," Walker Process fraud before the United States
Patent and Trademark Office (USPTO), "sham" IP enforcements and Food
and Drug Administration (FDA) petitioning, and other allegations of
improper conduct to delay or inhibit generic competition. Our deep and
longstanding connections with our clients ensure that our lawyers
bring genuine commercial knowledge in the sector to each challenge.
Our singular focus on understanding our clients' success and long-term
strategies sets us apart. We commit to fully understanding our
clients' businesses–their financial considerations and risk
tolerance, as well as the competitive and regulatory environments in
which they operate. View all lawyers in Pharmaceuticals & Healthcare
AWARDS Impact Case of the Year–PfizerLMG Life Sciences Awards
2014 Life Sciences Group of the YearLaw360 2014 Antitrust Group of the
YearLaw360 2014, 2013, 2012 and 2011 "Sources appreciate the firm's
strong cross-border capabilities in addition to its sector-specific
knowledge which extends to the pharmaceutical and ‘other’
industries."Chambers Global 2013 " …contributed a very high level
of effort and creativity on our case, backed up by his long-term
experience and profound expertise"Chambers Global 2011 " …famed
for…work in the pharmaceutical sector"Chambers Global 2011
